SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sanofi – ‘6-K’ for 5/5/16

On:  Thursday, 5/5/16, at 8:54am ET   ·   For:  5/5/16   ·   Accession #:  1140361-16-63461   ·   File #:  1-31368

Previous ‘6-K’:  ‘6-K’ on / for 4/29/16   ·   Next:  ‘6-K’ on / for 5/9/16   ·   Latest:  ‘6-K’ on 4/25/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/05/16  Sanofi                            6-K         5/05/16    2:36K                                    Summit Fin’l Printing

Report by a Foreign Private Issuer   —   Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Sanofi 6-K 5-5-2016                                 HTML     11K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     16K 


6-K   —   Sanofi 6-K 5-5-2016


This is an HTML Document rendered as filed.  [ Alternative Formats ]




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K
 


REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

May 5, 2016

Commission File Number: 001-31368

SANOFI
(Translation of registrant’s name into English)
 

54, rue La Boétie, 75008 Paris, FRANCE
(Address of principal executive offices)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes No

If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
 



On May 5, 2016, Sanofi issued the press release attached hereto as Exhibit 99.1, which is incorporated herein by reference.

Exhibit List

Exhibit
No.
 
Description
   
 
Press release issued by Sanofi dated May 5, 2016.
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SANOFI
   
 
By
 
Name:
 
Title:
Head of Securities Law and Capital Markets


Exhibit Index

Exhibit
No.
 
Description
   
 
Press release issued by Sanofi dated May 5, 2016.




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘6-K’ Filing    Date    Other Filings
Filed on / For Period End:5/5/16None on these Dates
 List all Filings 
Top
Filing Submission 0001140361-16-063461   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 2:00:51.2pm ET